Nifty
Sensex
:
:
17843.15
60614.72
121.65 (0.69%)
328.68 (0.55%)

Pharmaceuticals & Drugs - Global

Rating :
31/99

BSE: 530549 | NSE: SHILPAMED

241.40
08-Feb-2023
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  • 244.90
  • 250.00
  • 240.55
  • 244.60
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  96350
  •  235.31
  •  515.00
  •  231.80

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 2,097.57
  • 99.84
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 2,745.37
  • 0.46%
  • 1.18

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 50.01%
  • 8.56%
  • 21.85%
  • FII
  • DII
  • Others
  • 11.84%
  • 3.53%
  • 4.21%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 11.92
  • 7.75
  • 8.06

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 10.96
  • 5.45
  • -1.67

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 2.51
  • -11.61
  • -27.09

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 37.43
  • 27.57
  • 35.43

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.84
  • 2.53
  • 2.43

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 22.64
  • 19.39
  • 20.84

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 22
Sep 21
Var%
Jun 22
Jun 21
Var%
Mar 22
Mar 21
Var%
Dec 21
Dec 20
Var%
Net Sales
262.91
295.27
-10.96%
261.16
237.36
10.03%
340.59
208.03
63.72%
272.30
191.25
42.38%
Expenses
250.71
242.11
3.55%
240.59
205.48
17.09%
266.87
181.82
46.78%
227.21
170.28
33.43%
EBITDA
12.20
53.16
-77.05%
20.57
31.88
-35.48%
73.73
26.21
181.30%
45.09
20.97
115.02%
EBIDTM
4.64%
18.00%
7.88%
13.43%
21.65%
12.60%
16.56%
10.96%
Other Income
4.39
1.28
242.97%
8.10
1.99
307.04%
5.49
6.91
-20.55%
5.48
8.61
-36.35%
Interest
13.47
11.58
16.32%
9.59
10.32
-7.07%
9.35
9.12
2.52%
9.92
4.80
106.67%
Depreciation
23.31
19.18
21.53%
22.42
17.63
27.17%
22.34
15.23
46.68%
20.65
13.72
50.51%
PBT
-20.20
32.59
-
-3.34
5.92
-
47.41
8.76
441.21%
20.00
11.05
81.00%
Tax
-3.81
11.56
-
-6.41
3.56
-
16.86
0.80
2,007.50%
9.71
2.92
232.53%
PAT
-16.38
21.03
-
3.08
2.36
30.51%
30.55
7.96
283.79%
10.29
8.14
26.41%
PATM
-6.23%
7.12%
1.18%
1.00%
8.97%
3.83%
3.78%
4.25%
EPS
-2.15
2.45
-
0.10
0.19
-47.37%
3.40
0.96
254.17%
1.10
0.94
17.02%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Net Sales
1,136.96
1,145.52
901.13
907.91
733.39
788.83
779.16
716.43
613.80
571.38
371.32
Net Sales Growth
22.00%
27.12%
-0.75%
23.80%
-7.03%
1.24%
8.76%
16.72%
7.42%
53.88%
 
Cost Of Goods Sold
425.39
383.22
270.73
277.73
257.03
355.87
371.81
366.19
323.16
313.26
213.95
Gross Profit
711.57
762.30
630.40
630.18
476.36
432.95
407.36
350.25
290.63
258.12
157.38
GP Margin
62.58%
66.55%
69.96%
69.41%
64.95%
54.89%
52.28%
48.89%
47.35%
45.17%
42.38%
Total Expenditure
985.38
948.32
729.43
693.39
579.39
637.60
617.55
556.44
487.38
455.40
301.63
Power & Fuel Cost
-
52.43
40.25
38.76
33.57
28.86
26.30
21.90
19.29
17.37
10.67
% Of Sales
-
4.58%
4.47%
4.27%
4.58%
3.66%
3.38%
3.06%
3.14%
3.04%
2.87%
Employee Cost
-
264.49
235.31
196.59
176.40
149.35
127.87
90.09
82.30
67.83
42.56
% Of Sales
-
23.09%
26.11%
21.65%
24.05%
18.93%
16.41%
12.57%
13.41%
11.87%
11.46%
Manufacturing Exp.
-
124.11
91.29
79.19
61.23
59.96
52.55
45.35
36.55
27.44
16.92
% Of Sales
-
10.83%
10.13%
8.72%
8.35%
7.60%
6.74%
6.33%
5.95%
4.80%
4.56%
General & Admin Exp.
-
71.58
47.71
70.26
27.20
22.50
16.95
14.11
10.64
9.53
9.51
% Of Sales
-
6.25%
5.29%
7.74%
3.71%
2.85%
2.18%
1.97%
1.73%
1.67%
2.56%
Selling & Distn. Exp.
-
25.29
18.63
10.40
6.72
6.37
4.75
7.27
5.99
7.29
4.43
% Of Sales
-
2.21%
2.07%
1.15%
0.92%
0.81%
0.61%
1.01%
0.98%
1.28%
1.19%
Miscellaneous Exp.
-
27.22
25.51
20.47
17.23
14.68
17.32
11.54
9.45
12.68
4.43
% Of Sales
-
2.38%
2.83%
2.25%
2.35%
1.86%
2.22%
1.61%
1.54%
2.22%
0.97%
EBITDA
151.59
197.20
171.70
214.52
154.00
151.23
161.61
159.99
126.42
115.98
69.69
EBITDA Margin
13.33%
17.21%
19.05%
23.63%
21.00%
19.17%
20.74%
22.33%
20.60%
20.30%
18.77%
Other Income
23.46
20.90
40.09
22.22
15.56
32.62
29.34
11.36
6.93
9.12
5.01
Interest
42.33
41.17
21.87
4.56
3.68
2.66
3.13
3.93
4.05
3.52
2.27
Depreciation
88.72
79.80
53.98
43.78
42.06
37.22
30.64
23.14
21.41
23.22
15.34
PBT
43.87
97.13
135.95
188.40
123.82
143.96
157.17
144.28
107.89
98.35
57.10
Tax
16.35
41.68
48.85
33.49
26.18
33.91
42.04
35.62
35.22
20.30
9.53
Tax Rate
37.27%
39.35%
24.82%
17.78%
18.22%
23.56%
27.54%
25.11%
32.66%
21.27%
16.72%
PAT
27.54
60.66
147.78
156.50
120.28
112.43
113.71
109.84
73.69
75.67
47.35
PAT before Minority Interest
26.00
60.58
146.20
154.91
117.52
110.05
110.59
106.24
72.62
75.15
47.47
Minority Interest
-1.54
0.08
1.58
1.59
2.76
2.38
3.12
3.60
1.07
0.52
-0.12
PAT Margin
2.42%
5.30%
16.40%
17.24%
16.40%
14.25%
14.59%
15.33%
12.01%
13.24%
12.75%
PAT Growth
-30.26%
-58.95%
-5.57%
30.11%
6.98%
-1.13%
3.52%
49.06%
-2.62%
59.81%
 
EPS
3.17
6.99
17.03
18.03
13.86
12.95
13.10
12.65
8.49
8.72
5.46

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Shareholder's Funds
1,822.19
1,478.67
1,329.36
1,197.58
1,085.03
986.90
639.26
546.94
396.45
320.42
Share Capital
8.68
8.15
8.15
8.15
8.15
8.01
7.71
7.71
7.36
4.90
Total Reserves
1,813.51
1,470.51
1,321.21
1,189.43
1,076.88
978.88
631.55
539.23
389.09
315.52
Non-Current Liabilities
452.82
561.37
256.94
166.62
153.48
251.26
67.23
154.15
104.53
98.51
Secured Loans
353.49
473.87
164.48
80.39
67.09
141.20
0.03
71.03
37.43
70.47
Unsecured Loans
0.11
0.35
0.53
0.70
1.03
1.30
0.00
31.30
30.05
0.00
Long Term Provisions
19.08
15.48
26.17
21.77
20.32
16.89
13.96
11.75
9.93
6.92
Current Liabilities
611.54
543.29
410.82
253.44
265.84
236.90
222.07
189.06
166.84
123.77
Trade Payables
146.04
67.25
92.55
80.72
103.74
111.86
106.48
75.50
92.98
51.26
Other Current Liabilities
240.13
219.33
142.10
81.62
59.59
28.03
36.49
49.32
38.23
23.38
Short Term Borrowings
202.90
243.40
165.27
86.58
98.12
92.41
74.10
58.47
30.27
45.07
Short Term Provisions
22.46
13.31
10.89
4.52
4.39
4.60
5.00
5.77
5.37
4.06
Total Liabilities
2,875.50
2,572.16
1,989.21
1,610.02
1,499.13
1,472.22
930.89
904.54
677.83
551.42
Net Block
1,341.84
1,110.53
650.44
558.01
534.20
491.93
393.41
316.06
294.42
180.67
Gross Block
1,725.77
1,421.10
986.42
853.16
793.24
704.89
582.20
476.34
448.38
300.89
Accumulated Depreciation
383.93
310.57
335.98
295.15
259.04
212.96
188.79
160.28
153.96
120.22
Non Current Assets
1,988.30
1,729.60
1,365.35
1,064.96
827.16
742.33
576.68
576.77
443.89
339.18
Capital Work in Progress
506.18
541.29
666.25
429.12
209.85
140.51
91.90
221.62
111.03
129.15
Non Current Investment
34.23
21.22
10.45
2.25
20.79
27.99
34.15
0.19
0.21
0.14
Long Term Loans & Adv.
93.90
43.10
32.42
48.75
37.47
77.09
51.86
38.74
38.18
28.82
Other Non Current Assets
12.15
13.46
5.78
26.84
24.86
4.80
5.36
0.16
0.06
0.40
Current Assets
887.19
818.99
623.85
545.06
671.97
729.88
354.21
327.61
233.74
211.99
Current Investments
0.00
0.00
0.00
0.00
119.54
224.62
59.63
65.35
10.14
50.28
Inventories
355.24
316.84
226.43
187.67
188.71
190.00
134.23
130.78
123.25
74.33
Sundry Debtors
386.33
217.50
246.79
203.73
220.27
170.93
125.43
81.37
67.96
41.79
Cash & Bank
34.11
123.11
44.56
94.54
73.83
100.39
11.03
18.42
9.19
16.87
Other Current Assets
111.52
98.73
76.81
45.04
69.62
43.95
23.90
31.69
23.20
28.72
Short Term Loans & Adv.
102.16
62.81
29.25
14.08
43.54
21.95
8.90
4.91
3.23
2.86
Net Current Assets
275.66
275.69
213.04
291.62
406.13
492.98
132.14
138.55
66.90
88.22
Total Assets
2,875.49
2,548.59
1,989.20
1,610.02
1,499.13
1,472.21
930.89
904.54
677.83
551.42

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Cash From Operating Activity
105.13
46.93
124.38
146.78
44.92
37.48
128.70
68.81
70.04
43.64
PBT
102.26
196.79
188.40
143.70
136.77
146.49
140.36
107.84
95.45
57.00
Adjustment
109.34
4.03
41.32
20.44
18.83
17.19
20.61
26.46
19.62
11.52
Changes in Working Capital
-71.99
-106.29
-63.15
18.71
-69.66
-92.61
-2.70
-40.11
-23.44
-13.90
Cash after chg. in Working capital
139.62
94.53
166.57
182.85
85.94
71.08
158.27
94.19
91.62
54.62
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-34.48
-47.60
-42.20
-36.07
-41.02
-33.60
-29.56
-25.38
-21.58
-10.98
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-285.50
-404.28
-289.52
-196.16
-8.76
-262.23
-109.20
-195.18
-48.93
-95.21
Net Fixed Assets
385.38
-272.02
-4.28
-256.96
-136.75
-172.23
-92.14
-78.46
-61.02
-83.52
Net Investments
-18.18
-125.84
-4.44
141.85
95.51
-172.72
-14.09
-64.38
12.08
13.84
Others
-652.70
-6.42
-280.80
-81.05
32.48
82.72
-2.97
-52.34
0.01
-25.53
Cash from Financing Activity
82.86
436.37
175.50
10.06
-60.91
312.70
-19.65
135.05
-28.34
66.31
Net Cash Inflow / Outflow
-97.51
79.03
10.36
-39.32
-24.75
87.95
-0.15
8.68
-7.23
14.74
Opening Cash & Equivalents
122.85
44.31
34.13
73.83
99.97
7.05
3.61
9.19
16.87
2.27
Closing Cash & Equivalent
25.34
123.34
44.31
34.36
73.83
99.97
6.43
18.42
9.19
16.87

Financial Ratios

Consolidated /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Book Value (Rs.)
209.93
181.37
163.06
146.89
133.09
123.17
82.91
70.92
107.72
43.52
ROA
2.20%
6.33%
8.61%
7.56%
7.41%
9.20%
11.58%
9.18%
12.23%
9.64%
ROE
3.67%
10.41%
12.26%
10.30%
10.62%
13.60%
17.92%
15.40%
20.98%
15.93%
ROCE
5.94%
10.73%
12.41%
11.05%
11.71%
15.91%
19.90%
17.90%
20.48%
15.04%
Fixed Asset Turnover
0.73
0.75
0.99
0.89
1.06
1.22
1.36
1.34
1.54
1.32
Receivable days
96.20
94.03
90.56
105.51
90.20
69.00
52.26
43.99
34.62
39.70
Inventory Days
107.07
110.03
83.24
93.66
87.32
75.49
66.97
74.84
62.33
68.31
Payable days
101.58
107.72
47.69
58.00
61.51
60.89
60.10
62.86
57.06
63.94
Cash Conversion Cycle
101.69
96.33
126.11
141.17
116.00
83.61
59.13
55.97
39.90
44.07
Total Debt/Equity
0.37
0.57
0.29
0.16
0.18
0.24
0.14
0.34
0.30
0.41
Interest Cover
3.48
9.92
42.34
40.09
55.10
49.69
37.07
27.63
28.09
26.13

News Update:


  • Shilpa Medicare introduces Capecitabine 1000 MG dispersible tablet
    17th Dec 2022, 16:27 PM

    The company has launched the product in the Indian market on December 16, 2022

    Read More
  • Shilpa Medicare’s Telangana facility gets Health Canada GMP approval
    1st Dec 2022, 16:11 PM

    This GMP approval will allow the company for the commercial distribution of products in Canada and enable new application submissions to Health Canada

    Read More
  • Shilpa Medicare - Quarterly Results
    11th Nov 2022, 17:10 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.